Skip to main navigation
logo
SAB Biotherapeutics Logo
  • Home
  • News & Events
    News Releases Events Presentations Publications
  • Governance
    Governance Overview Executive Management Board of Directors Committee Composition
  • Financial
    SEC Filings
  • Stock
    Stock Quote & Chart Analyst Coverage
  • Shareholder Services
    Investor FAQs Email Alerts RSS Feeds

SEC Filing Details

Document Details

Form
8-K/A
Filing Date
Nov 22, 2021
Document Date
Oct 22, 2021
Form Description
Amendment to a previously filed 8-K
Filing Group
Current Reports
Company
SAB Biotherapeutics
Issuer
SAB BIOTHERAPEUTICS, INC.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.DEF - XBRL DEFINITION FILE
EX-101.LAB - XBRL LABEL FILE
EX-101.PRE - XBRL PRESENTATION FILE
XML - XBRL INSTANCE DOCUMENT

Shareholder Tools

  • Print Page
  • Email Alerts
  • RSS
  • Investor FAQs
  • © SAB Biotherapeutics 2022

Footer Links

  • Terms & Conditions
  • Privacy Policy